Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 3 1

Status

Recruiting 3Completed 3Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 3NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 1Breast 1

Conditions

Sedentary Behavior 1Prostatic Neoplasms 1Muscular Atrophy 1Muscle Weakness 1Motor Activity 1Fatigue 1Cachexia 1Breast Neoplasms 1Body Weight Changes 1Anorexia 1

Interventions

Cyclophosphamide 956Radiotherapy 847Cisplatin 757Gemcitabine 657Carboplatin 603Docetaxel 598Paclitaxel 585Bevacizumab 580Fluorouracil 504Oxaliplatin 458Rituximab 453Surveys and Questionnaires 449Capecitabine 440Dexamethasone 428Doxorubicin 424Etoposide 411Irinotecan 389Cytarabine 376Filgrastim 369pembrolizumab 330Leucovorin 305Nivolumab 296fludarabine phosphate 294Melphalan 288Magnetic Resonance Spectroscopy 281Peripheral Blood Stem Cell Transplantation 279Blood Specimen Collection 279Methotrexate 276Lenalidomide 276Cetuximab 270

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × OTHER × Creatine × Clear all
NCT03987217 2025-05-14

Resistance Training +/- Creatine for Metastatic Prostate Cancer Patients

University of Utah

Phase EARLY_PHASE1 Completed
73 enrolled
Genitourinary

Fatigue, Prostatic Neoplasms, Sedentary Behavior

NCT04207359 2023-07-25

Effects of Creatine Supplementation in Breast Cancer Survivors

The University of Texas Health Science Center at San Antonio

Phase NA Completed
20 enrolled
Breast

Breast Neoplasms, Motor Activity, Muscular Atrophy, Muscle Weakness

NCT00081250 2020-04-29

Creatine in Treating Patients With Cancer-Associated Weight Loss

Alliance for Clinical Trials in Oncology

Phase 3 Completed
300 enrolled

Anorexia, Body Weight Changes, Cachexia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡